✓ No active regulatory warningsFDA MedWatch, EMA EudraVigilance, WHO VigiBase, WADA Prohibited List · 2026-05-29
📰Read the full Olive Leaf Extract evidence review on GMJ News →Complete clinical article, references and updates on news.gmj.ge. This page is the structured safety summary.⚠ One RCT comparable to captopril — but single trial needs replication [2]
⚠ Additive BP lowering with antihypertensives [2]
ℹ️ Not obtained from food. Not applicable — this is not obtained from food in meaningful amounts; supplementation is the practical route.
🔬 Lab interpreter
Recommended test
Blood pressure
Blood pressure
Reference range / target
<130/80
<130/80
~5 mmHg SBP reduction expected [2].
Full lab monitoring ↓⚕ For professionals — confirm ranges against your local laboratory.
Clinical verdict
1 How much do I need?
👤 Adults: Specific dosage data under clinical review
👴 Elderly: Specific dosage data under clinical review
🤰 Pregnancy: See guidance
Limited data. Avoid [1].
👦 Pediatric: See guidance
No data [1].
🏃 Athletes: Standard dose
⚖️ Obesity: Standard dose
Fat-soluble compounds may require dose adjustment in obesity.
🩺 Renal: Consult specialist
Dose adjustment may be needed in renal impairment.
🌱 Vegan: Standard dose
How to take
🍽 Timing: BID with meals [2].
💊 With food: With food [1].
🚫 Avoid: Concurrent antihypertensives without monitoring [2].
2 Which form?
| Form | Bioavailability | Vegan | Cost |
|---|---|---|---|
| ['Standardized extract (15–20% oleuropein)', 'preferred', '500 mg BID. Most clinical data [2].'] | Standard | Check label |
3 Common questions
Is olive leaf comparable to blood pressure medication? ▼
One small RCT found 500 mg BID comparable to captopril 12.5 mg BID for mild hypertension. This is a single trial — not enough to replace medication, but promising as a natural option for prehypertension or mild hypertension [2].
4 Clinical evidence
Strong
Oleuropein and hydroxytyrosol are potent antioxidants — well-characterized [1]. HIGH
Moderate
Blood pressure: one RCT found olive leaf 500 mg BID comparable to captopril 12.5 mg BID for stage 1 hypertension (SBP ~5 mmHg reduction) [2]. Lipids: modest LDL reduction in some trials [2]. Antimicrobial: in vitro activity against bacteria, viruses, fungi [1]. MODERATE
Insufficient
5 Safety, toxicity & adverse events
Relative
⚠ Antihypertensives — additive blood-pressure lowering
⚠ Antidiabetics — additive glucose lowering
⚠ Anticoagulants — possible additive effect
⚠ Pregnancy and lactation — limited data
🚩 Red flags
● Patient replacing BP medication with olive leaf based on one trial — premature [2]
6 Interactions
Drug interactions
Antihypertensives Moderate
Mechanism: Additive BP lowering. [2]
Effect: Hypotension risk. [2]
Action: Monitor BP [2].
Supplement synergies
CoQ10 · 100–200 mg CoQ10
Complementary cardiovascular effects [1].
Complementary cardiovascular effects [1].
7 Regulatory
European Union: EFSA: authorized health claims for olive oil polyphenols (hydroxytyrosol) for LDL oxidation protection [1].
United States: Dietary supplement [1].
8 US supplement products
11
on-market products containing Olive Leaf Extract (NIH DSLD)
Brands carrying Olive Leaf Extract (3)
Click a brand to see its Olive Leaf Extract products.
9 Frequently paired with
10 Cite this page
Vancouver: Pkhakadze G. Olive Leaf Extract — safety profile [Internet]. Tbilisi: PHIG; 2026 [cited 2026 Aug 15]. Available from: https://supplement.ge/ingredients/olive-leaf-extract/
APA 7th: Pkhakadze, G. (2026). Olive Leaf Extract — Safety profile. Public Health Institute of Georgia. https://supplement.ge/ingredients/olive-leaf-extract/
📋 Editorial information
Author: Prof. G. Pkhakadze, MD, MPH, PhD
Institution: Public Health Institute of Georgia (PHIG)
Affiliation: David Tvildiani Medical University (DTMU)
First published: January 2026
Last reviewed: 2026-05-29
Next review: February 2027
References: 2 cited sources
COI: SupplementIndex receives no funding from supplement manufacturers. All content independently authored by PHIG.
Process: Systematic literature review
📄 License & reuse
Published under Creative Commons Attribution 4.0 International (CC BY 4.0). You may share and adapt for any purpose with attribution.
Pkhakadze G. "Olive Leaf Extract — Safety Profile." SupplementIndex, PHIG, 2026. https://supplement.ge/ingredients/olive-leaf-extract/ CC BY 4.0.
GP
Prof. G. Pkhakadze, MD, MPH, PhD
Professor of Public Health · Head of Department, DTMU
Editor-in-Chief, Georgian Medical Journal (ISSN 3088-4322)
Chair, Public Health Institute of Georgia · UEMS Public Health Section
Educational and public health purposes. CC BY 4.0. Consult your healthcare provider before starting any supplement. Corrections: info@accreditation.ge. Publisher: PHIG